Trial to Evaluate Efficacy and Safety of Subcutaneous Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma .
Clinical trial NCT07191249 · RECRUITING
Trial details
- NCT number
- NCT07191249
- Sponsor
- Tel-Aviv Sourasky Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2028-04-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.